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I T HAS BEEN almost a decade since the first attempt 
was made to treat a child with hepatic glycogen 
storage disease by portal diversionK~s On the basis of 
animal experiments,23.28 it was hoped to make dietary 
glucose more readily available to peripheral tissues, 
to cOincidentally deglycogenate the liver, and to pal-
liate other complications such as acidosis. This patient, 
as well as a second one described by Riddell, Davies, 
and Clark21 had the operation of po~tacaval transposi-
tion, a procedure developed in dogs by Child· and as-
sociates5 whereby the diverted portal inflow is replaced 
with venous blood from the suprarenal inferior vena 
cava. 
Although the transposition was used in order to avoid 
the potential hazards of Eck fistula, it was suggested 
in our original report and in subsequent ones by Her-
mann and Mercerll and ourselves25 that an end-to-side 
portacaval anastomosis probably would be just as 
effective and that certainly it would be technically 
safer by virtue of omission of the second venous anasto-
mosis. The simpler procedure of portcaval shunt has 
been used in all subsequent cases that have appeared 
in the literature2 ,6,9 as well as for the last five cases 
in our series herein reported. Folkman and associates 
have recently shown that a further reduction of opera-
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tive risks in patients with glycogen storage should be 
pOSSible by parenteral hyperalimentation and conse-
quent preoperative amelioration of hepatomegaly, aci-
dosis, and other metabolic abnormalities.9 
The present communication has two general purposes. 
The first is clinical. Our own as well as the collected 
world experience with portal diversion for hepatic 
glycogen storage disease will be recounted, adding 
now to a total of 13 cases and including follow-ups 
of 9~ and 8 years, respectively, for our oldest patient 
and for Riddell's patient21 who immigrated from Bris-
tol, England, to Canada in 1968. This latter boy was 
recently seen and studied in Denver along with our own 
six surviving patients. Emphasis will be placed on the 
long-term relief of the metabolic disturbances and 
growth retardation in patients with deficiency of three 
different kinds of enzymes: glucose-6-phosphatase (Type 
I), amylo-1-6-glucosidase (Type III), and phosphory-
lase (Type VI). 
The second objective will be to consider the reasons 
why portal diversion has been so valuable, Partly on 
the basis of experiments recently carried out in dogs,:!\; 
it will be suggested that the multiple and striking bene-
fits of portal diversion in glycogen storage disease de-
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rive more from the bypassing of pancreatic hormones 
(particularly insulin) around the liver than by the 
simple rerouting of alimentary glucose as was originally 
believed. 
Methods 
There were seven patients in the Colorado series with 
the ages and the enzyme defects shown in Table 1"'. In 
addition, the patient reported from Bristol, England, by 
Riddell, Davies and Clark21 was studied including bi-
opsy 7% years postoperatively. Determination of the 
" Typcs I, III, ano VI arc the hepatic glycogenoses which might 
theoretically benefit from portal diversion. At our institution, a 
23-month-olU chilo from Christchurch, J\'ew Zealand, with Type 
IV glycogen storage diseasc (a-l,4-glucan: a-l,4-glucan 6 glycosyl 
transferase deficiency) received a side-to-sioe portacaval anasto-
mosis but not with the metabolic objectives of the present report. 
With Type IV disease, an abnormal glycogen resemhling amy-
lopectin which apparently causes a foreign body tissue reaction 
is deposited in the liver and causes progressive cirrhosis that leads 
to death at the age of 2 years or younger. The portacaval shunt 
was performed in -an attempt to control massive ascites but death 
followed 1 month later from hepatic insufficiency and a hemo)vtic 
crisis. 
enzyme defects in the Colorado cases was by biochem-
ical analysis in the St. Louis Laboratories of liver wedge 
biopsies which were obtained hefore or at the time of 
portacaval diversion and frozen on dry ice. The meth-
ods of analysis as well as the disease classification ac-
cording to numerical types have been well accepted in 
standard endocrinology and metabolism texts.3.13.22 
The major complaints of the children or their par-
ents were varia hIe (Table 1). All of the patients were 
stunted in growth and in Case 5 this was the most im-
portant complaint. Episodic hypoglycemia was docu-
mented in all but Case 5. Patients 2, 3, and 4 (all Type 
I disease) had recurrent metabolic acidosis with lactic 
acidemia which had required numerous hospitalizations 
for therapy. The same three patients had repeated 
seizures. Other miscellaneous prohlems arc mentioned 
in Table 1. Patients 6 and 7 were brother and sister; 
a sibling died at age 5, apparently of metabolic com-
plicatiOns of glycogen storage disease. Two siblings of 
patient 2 died of hypoglycemia and acidosis. 
The kind of portal diversion is indicated in Table 1. 
Our first two patients had portacaval transposition; 
cnd-to-side portacaval shunt was used for the last 5. 
TABLE I. Patients with Glycogen Storage Disease Treated or Studied at the University of Colorado 
Case No. 
2 
4 
.'5 
6 
7 
Bristol 
Ageat 
Operation 
7 
7 
11 
10 
5 
3 
7 
Type 
VI 
III 
III 
Glycogen Storage Disease 
Enzyme Deficicncy 
Amylo·l,6-glucosidasc 
Glllcose-6-phosphatnse 
Glllcose-6-phosphatase 
Glllcose-6-phosphatase 
Heduced liver phosphorylase 
Amylo-I,6-glucosidase 
Glllcose-6-phosphatasc 
Type and Date of 
Portal Diversion 
Portacaval Transposition 
10/15/63 
Portacaval Transposition 
6/26/68 
Portacaval shunt 
5/2.'72 
Portacaval shunt 
5/17/72 
Portacaval shunt 
8/2/72 
Portacaval shunt 
11/7/72 
Portacaval Shullt 
11/8/72 
Portacaval Transposi tion 
5/5/65 
Major SYlllptoms 
----
Hypoglycemia 
Gf bleeding 
~ose bleeds 
Retardation of growth 
Abdominal distension 
Hypoglycemia 
Acidosis 
Convulsions 
Retardation of growth 
Hypoglycemia 
_\cidosis 
Convulsions 
Retardation of growth 
~ose bleeds 
Skeletal deformity 
Hypoglyccmia 
l\cidosis 
Convulsions 
Retardation of growth 
Symptomatic hyperllficiemia 
Lethargy 
Retardation of growth 
Hypoglycemia 
Acidosis 
Retarda tion of growth 
Hypoglycemia 
Acidosis 
Retardation of growth 
Hypoglycemi:l 
Convulsions 
Retardation of grOWl h 
Abdominal distension 
Respiratory infecti911s 
Intellectual retardation 
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In Cases 3, 4, 6, and 7 parenteral hyperalimentation as 
described by Folkman et al,9 was used for 29, 13, 6, 
and 7 days. When performing the end-to-side portacaval 
shunts, all tributaries of the portal vein were ligated 
and divided from just above the pancreas to the di-
vision into the right and left portal branches. An elipse 
was removed from the vena cava. The back wall of the 
portacaval anastomosis was sutured from the inside and 
the anterior wall was completed externally.27 Postop-
eratively, hyperalimentation was continued until the 
patient resumed an oral diet and then tapered and dis-
continued from 6 to 8 days postoperatively. 
Growth was assessed by measurements of height and 
weight and by serial radiographic studies. The latter 
usually included wrist and hand X-rays, which were 
graded for bone age by the standards of Greulich and 
Pyle10 and for osteoporosis. Because of the variahility 
of height measurements, lower extremity scanograms 
employing a calibrated steel rule were obtained. In 
Cases 3-7, serum alkaline phosphatase, calcium, phos-
phorus, and magnesium concentrations were obtained 
before and serially after operation and 24-hour urine 
calcium and phosphorus excretion was measured. These 
remained normal throughout except for a transient and 
minor hypocalcemia immediately postoperatively in four 
of the five patients in whom full data were obtained. 
The effect of hyperalimentation and/or portal di-
version upon liver size was determined quantitatively 
with colloidal gold (Case 1) or 99M technetium (Cases 
3-7) sequential scans, using planimetry in some in-
stances. Kidney size was followed by similar measure-
ments of anteroposterior renal scans or by determining 
the supero-inferior length of the right or left kidney on 
intravenous urograms. 
Standard liver function examinations were routinely 
ohtained before and after operation, including serum 
bilirubin, alkaline phosphatase, SGOT, SGPT, lactic 
dehydrogenase (LDH), prothrombin time, total pro-
tein and electrophoresiS, and plasma ammonia. Fasting 
venous plasma sugars, lactates, pyruvates, and pH's 
were measured. Five-hour glucose tolerance tests were 
performed with glucose sampling at 0, 30, 60, 90, 120, 
180, 240, and 300 minutes. In many of these tests in-
sulin concentration18 and pH of the venous blood sam-
ples were also analyzed. 
The serum lipid components, cholesterol, triglycer-
ides phospholipids (expressed as lecithin), and unesteri-
fied fatty acids were repeatedly examined hefore and 
after operation Lipoproteins were analyzed by cellu-
lose acetate electrophoreSis in Cases 3-7 at frequent 
intervals, particularly in the patients with Type I dis-
ease. 
Renal function was followed with blood urea nitro-
gen (BUN), creatinine and creatinine clearance de-
terminations and with examination of urine electrolytes, 
urea, proteins and sediment; deterioration of function 
never occurred. Plasma uric acid concentration and 
urine uric acid secretion were measured. 
Complete blood counts including white cell differen-
tial and quantitative platelet counts were followed. Mi-
nor abnormalities of several clotting factors have previ-
ously been reported for Case 1.28 Patients 3-7 were 
screened for platelet defects prior to hyperalimentation 
or operation. The tests performed included a platelet 
count, Ivy bleeding time, prothrombin consumption,29 
platelet aggregation," and in vitro platelet adhesive-
ness.31 Major abnormalities of platelet function were 
discovered only in Cases 3 and 4. These patients had 
Type I disease, and both had follow-up platelet stud-
ies. 
Needle or open hiopsies were performcd from 4 to 
113 months after portal diversion in all six of the sur-
viving Colorado patients as well as in Riddell's patient. 
The tissues were examined by light microscopy for evi-
dence of fibrosis, cirrhosis and hepatitis. The amount 
of fat in the cells was determined in frozen sections. 
'Vhen pre- and postoperative biopsies were available 
the size of the hepatocytes before and after portal di-
version were determined hy a method previously de-
scrihcd.2G Electron microscopy was also used on the 
biopsies from six of the eight patients. In addition to 
the histopathologic examinations, the postoperative tis-
sues were measured for glycogen concentration and if 
there was sufficient tissue, analysis was carried out of 
the enzymes studied preoperatively. 
In addition to studying the Colorado cases and Rid-
dell's English patient, personal inquiries were· made 
about the fate of the other five patients reported in the 
literature to have had portal diversion procedures. 
Since this information was obtained in April, 1973, 
follow-up data may be considered relatively complete 
for every patient known to have been submitted to this 
kind of surgical therapy. 
Results 
Mortality and Morbidity 
Portacaval Transposition. Our first patient had a re-
markably untroubled convalescence and was discharged 
from the hospital nine clays postoperatively. Before and 
after operation, there were elevations in the trans am-
inases (Table 2), which even 9~ years later are still 
slightly increased. She had a splenectomy 43 months 
after transposition for thrombocytopenia at which timc 
the portacaval anastomosis draining the splanchnic bed 
was proved to be open. When this patient was seen 9~ 
years postoperatively in March, 1973, there was no 
.. Ghronolog plateJet aggrcgometer. 
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evidence of portal hypertens ion indicating that the 
portacav al anastomosis draining the splanchnic bed was 
still open. An inferior vena cavagram revealed flow 
of systemic venOllS blood from the distal vena cava to 
the liver but with a major bypass around the liver from 
azygous and hemiazygous collaterals (Fig. 1). The de-
gree of natural shunting was similar to that observed 
with a comparable angiographie study more than 9 
years earli er when the patient was 3 months postopera-
tiveK~~ 
The anastomosis through which the vena cava drains 
has failed in two other cases. The attempt at trans-
position cost the life of our second patient, when the 
liver was unable to transmit the rerouted vena caval 
flow, causi ng hepatic svvelling and uncontrollable aci-
FIG. 1. Inferior vena cav-
agram in March, 1973, 
9F~ years postoperatively 
in Colorado Case 1 show-
ing a patent caval-portal 
anastomosis (arrow) un-
der two conditions of dye 
injection. Significant flow 
through the liver, as well 
as around it by the 
azygous and other col-
la terals were well seen at 
fluoroscopy. IVC-distal 
inferior vena cava; LRV 
-left renal vein; PV-
portal vein. 
dosis.25 In Riddell's case, angiographic studies were 
carried out in Calgary, Alberta, in December, 1971, by 
Dr. Robert J. Sommerville and Dr. Noel Hershfeld, 
and confirmed by us in January, 1973. The vena cava 
was obstructed (Fig. 2, left), a complication which 
probably occurred a long time previously since collat-
eral venous channels were highly developed and lower 
limb edema was minimal. The anastomosis draining the 
splanchnic venous bed was shown to be open (Fig. 2, 
right) . 
End-to-Side Portacaval Shunt. Patients 3-7 all had 
rapid recovery without any clinically eviden t morbidity 
ascriba ble to the procedure. Significant increases in 
SCOT and SCPT were usually present at some time 
preoperatively both before and at the time of paren-
FIG . 2. Studies of the 
Bristol case of portacaval 
transposition. The orig-
inal operation was on 
May 5, 1965, and the 
examination depicted 
which was in December, 
1971, was performed by 
Dr. R. J. Sommerville at 
the Foothills Hospital, 
Calgary, Alberta. (Left) 
Inferior vena cavagram 
shOWing obstruction at 
the anastomotic site ( ar-
row). lVC-distal infe-
rior vena cava; LRV-
left renal vein. Note the 
extensive collaterals via 
the azygous system . 
( Right) Demonstration 
of a patent portacaval 
anastomosis (arrow) by 
means of a retrograde 
catheterization . IVC-
proximal i~ferior vena 
cava; PV-portal vein . 
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teral hyperalimentation. After operation the trans am-
inasemia continued and the transaminase rises have 
been persistent in three of the five cases (Table 2). 
Minor and transient elevations of lactic dehydrogenase 
and alkaline phosphatase were also noted. 
None of the five patients was jaundiced immediately 
prior to operation, although patient 3 had had mild 
hyperbilirubinemia just before beginning hyper-alimen-
tation. The bilirubin returned to and remained normal 
after operation. The other liver function tests, including 
serum protein electrophoresis, were always normal post-
operatively. 
The patients were placed on a normal diet after op-
eration with no restrictions in protein intake. No clinical 
evidence of hepatic encephalopathy was observed and, 
in fact, the patients' parents without exception noted 
increased animation and mental acuity. Blood ammonia 
levels were always normal. 
Effects on Growth 
Thc remarkable increase in height in Case. 1 was re-
ported previouslyK~o This child weighed 29 Kg. prior to 
operation and ,vas 124.5 cm. tall. Eleven months later 
she had gained 4)fKg. weight and 11Jf cm. in height. 
On the Harvard growth chart this jump in height rep-
resented a change from less than the 10th to the 50th 
percentile. By June, 1967, 44 months post-transplanta-
tion, her height had increased to 155 cm. At present, 
she is 172 cm. tall and weighs 82.7 Kg. Her weight 
and height positions on the growth chart are now over 
the 97th percentile levels. 
Accelerated growth has now become evident in the 
three children with the longest follow-ups after end-
to-side portacaval anastomosis (Cases 3-5), averaging 
0.5 to 1.0 cm. per month of height increase, as well as 
commensurate increases in the more accurately quan-
tifiable long bone length in the 8Jf to 11Jf months of 
follow-up (Table 3). The phenomenal effects of doub-
ling the bone age in Case 3 (Table 3) can be visually 
appreciated by comparison of the wrist and hands with 
X-ray examination (Fig. 3). Patients 3, 4 and 5 also 
had calcification of previously osteoporotic bones. This 
was particularly striking in Case 5 (Fig. 4). The last 
two patients have not yet begun accelerated growth. 
Effect on Organ Size 
Liver. As described by Folkman,9 both the patients 
with Type I disease (Cases 3 and 4) had declines in 
liver size following hyperalimentation and these de-
creases were maintained after end-to-side portacaval 
shunt. The child with Type VI disease (Case 5) was 
not prepared with hyperalimentation but he also had 
a postoperative decrease in hepatomegaly (Fig. 5). 
This effect of operation was not a striking feature of 
the recovery in Cases 1, 6, and 7. These children had 
Type III disease. The minimal or absent liver shrinkage 
was previously noted in Case l.25.28 In that patient, it 
was pOinted out that with the increased body growth 
and fixed liver size, the child grew up around the en-
larged organ to the extent that its relative although 
not its absolute size decreased. 
Kidney. Kidneys in patients 4-7 appeared to have 
slight decreases (4 to 12 mm) in size during the 5 to 
11 months of follow-up (Fig. 6). Quantitative data on 
kidney size was not available in Cases 1 and 3. 
Metabolic Effects 
Carbohydrates. With the exception of the child with 
Type VI disease (Case 5), all patients before operation 
had documented fasting hypoglycemia which caused 
TABLE 2. SGOT Values (Normal 3-27 International Units) before 
and after Portal Division. Note That All the Patients Had Significant 
Abnormalities Preceding Treatment 
Case Number 
Days before ( - ) and 
after operation ( +) 3 4 5 6 7 
30 250 650 
15 75* 37 910 
10 220 88· 11· 690 470 
5 179* 66* 197 131* 392* 
0 110* 188" 60* 185* 
+ 1 220 182 218 387 216 343 
+ 2 190 296 106 332 
+ 3 255 321 84 
+ 4 
+ 5 36 699 271 
+ 6 236 51 813 168 
+ 7 30 571 316 
+ 8 40 510 198 
+ 9 16 473 305 
+ 10 67 308 311 
+ 11 
+ 12 49 
+ 13 58 
+ 14 300 
+ 15 49 
+ 16 
+ 17 142 
+ 18 
+ 19 
+ 20 151 
+ 21 280 
+ 77 64 
+ 84 198 
+109 125 
+127 568 838 
+159 40 
+208 41 
+253 174 
+258 294 
+264 69 
+295 35 
+315 36 
9 Yr 5 Mo 40 
,. Receiving hyperalimentation 
530 STARZL AND OTHERS Ann. Surg .• October 1973 
TAOLE 3. Age, Height, and W eight Data of Seven Patients Who Underwent Portal Division. Patients 1 and 2 llad Portacaval Transposition. 
The Other 5 Had End-to -side Portacaval Sh unt 
Pos torera ti ve Pos tore r<1t ive Weight G ai n 
H e igh t !ncre<1se Leg Length or Loss 
ChrOfloiogic Bon,eAge(Years) (CM) (CM) (KG) 
!\ge <It Tilllc of 
Operation Date of Follow-up At At At At 
Case No. (Years) Operation (Months) Operation Now Operation Now Operation Now Oreration Now 
81 10/ 15/ 63 113 No t done IS Yr 12·t 5 172 0 Not ava il ~lble 29 . 0 82 . 7 
( < I 0%) ( >97%) 
2 7 6/26/ 63 Died ill2 N o t done 91.4 14 . 7 
days ( <3%) 
3 7 5/2 / 72 IIi 3Yr61Vlo 7Yr4Mo 100 0 111. 3 -l--l- 6 5 1.4 20.1 31. 2 
( <3%) ( <3%) 
4 11 5/ 17/72 11 7YriOMo 7 Yr 10 Mo 11 8 . 7' 124. I 57. 0 60 2 27.6 27 . 7 
( < 3 %) ( <3%) 
5 10 8 / 2/72 8} 8 Yr6 M o 9 YIOM o 122 . 3 127 .S 59.8 6.J. .O 26 . 0 29 . .1 
( <3%) ( <3%) 
6 5 11 / 7/ 72 5 2 Yr 0 Mo 2 Yr 0 Mo 9".6 9-1- . 5 38 . 2 39 .4 15.8 IS. 
( <3%) ( <.1%) 
7 3 11 / 8/72 5 I YI6 Mo I Yr 6 Mo 85.S 85 . 5 3+.3 3-1- .5 13. 1 12 .8 
( <3%) ( <3%) 
Bristol 5/S/65 92 !.IYrOMo IS8 . S 43.6 
(25%) 
• In th e 3 yea rs preceding oper;]t ion, ;]CCLIrate hospit ~tf recoru s s bowed :1 to la l hcig-ht inuease of only 3 cm. The percentages ill p:1ren-
theses indicate percentile positiull On height growth chart. 
symptoms. This was prllticlllarly severe in Cases 3 and 
7 in which the fasting glucoscs were frcrillen tly below 
15 mg./100 m1. (to as low as 7 mg,/100 mI.) , After 
portal diversion, symptomatic hypoglycemia was no 
longer a significant problem in patients 1, 6, and 7 
(all Type III disease), The two children with Type I 
disease ( Cases 3 and 4 ) were improved but they were 
still unable to go without food for morc than 4 hours 
and 8 hours, respectively. 
Pre- and postoperative 5-hour glucose tolerance tests 
were obtained in five of our s ix survivors. In the sixth 
(Case 4), preopera tive tes ts could not be obtained 
because of the need for continuous parenteral hyper-
alimentation. In Cases 1 and 3 the glucose tolerance 
tests after 9F~ postoperative years and 1 year, respec-
tively, had a considerably increased hyperglycemic re-
sponsc to the ingested sugar (Fig. 7). The glucose 
tolerance tests in Cases 5, 6, and 7 were not much 
changed from 5 to 8 months after end-to-side por-
tacaval shunt. 
Insulin. Systemic insulin was measured during 5-
hour glucose tolerance tests in our six survivors and in 
the Bristol case. The examinations were 5, 5, U~I 11, 
11g~ I 92 and 113 months after portal diversion, The re-
sults are summarized in Figure 8. Super norm al insulin 
rcsponses were observed in three cases, a normal re-
sponse in a fourth , and su bnormal responses in the other 
three. The two patients who exhibited the Rattest in-
sulin curves were the ones \.vith Rat glucose tolerance 
tests. 
Lipids. Portal diversion caused a dramatic improve-
ment of the hypcrlipidemia of Type I disease (Cases 
FIG, 3. The dramatic 
wrist Jnd hand bone 
grow th in Case 3 in the 
first 11)1, postoperative 
m on ths . T he bracket on 
the left index finger is 
5 cm. in length. In ad-
di tion to the size change, 
note the minera lization 
th at has occurred, as well 
as the appea rance of new 
bones, particula rl y of the 
wrist. 
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Flc. 4. Changes in the 
hand iwel wrist bones of 
Case 5 during 812 post-
operative months. There 
was a gain in hand size, 
but the main change was 
rapid mineralization of 
the previously osteopo-
rotic bones. The brackets 
on the left index finger 
art' 7 em. 
3 and 4, Table 4). All of the lipid components were 
brought toward normal ranges by preoperative hyper-
alimentation and the improvement was sustained after 
portacaval shunt. The evolution of recovery of lipid 
COJlstitlwnts in Case 4 is shown in Figure 9, and in 
Figure 10 the lipid clearing is documented in terms of 
lipoprotein analysis. 
The portal diversion also had an acutcly ameliorat-
ing effect upon the much It'ss severe hyperlipidemia 
affecting the two most recently treated patients with 
Type III disease (Cases 6 and 7, Table 4). Howevcr, 
patient 4 had recurrence of elevated lipids in one sam-
ple at 5 months. At thc same time, the boy's sister did 
not have worsening of lipid values. The lipids were 
esse ntially normal before and after operation in the 
pati ent with phosphorylase deficiency (Case 5). 
Uric Acid. Four of the last five patients in the Colo-
rado series had elevated serum uric acid concentra-
tions. Aftt'r portal diversion, these concentrations fell 
either slightly or significantly in all four pati ents (Fig. 
11). Howcver, in Case 7, the uric acid was normal pre-
operatively and rose afterward just beyond normal 
range. 
P 1(1 telets. Major functional a bnorma Ii tics of pI ate-
lets were present in pati E'n ts 3 and 4. They had ab-
normall y prolonged bl eE'ding times, decrcased platelet 
adhesiveness, abnormal platelet aggregation reactions, 
and decreascd prothrombin consumption. The abnor-
mal platclet functions wcre rapidly corrected during 
intra vcnOllS hyperali men tation and remained normal 
afte r portal diversion, as reported in detail elsewhere' 
GrOl cth Hormone. Patients 3, 4, and 5 had plasma 
FIG. 5. AP 99111 technetium Iiwi scans in a child with Type VI 
(phosphoryla se deficien cy) disca se (Case 5). The cm" areas 
were obtained from the anteroposterior projections by planimetry. 
somatotropin determinations after portal diversion. The 
same investigations were performed for an unoperated 
Sibling of patient 4 for whom portacaval shunt is 
planned. In all four patients, the levels and circadian 
patterns of somatotropin were normal as were the re-
sponses to arginine stimulation. 
Histopathologic Studies 
Preoperative liver biopsies were available from six of 
the eight patients. In all the cases the livcr cells were 
large and pale-staining and had ccntrally placed nu-
clei (Fig. 12, top). The clear cytoplasm contained fat 
globules and much glycogen. The amount of reticulin 
in the portal tracts was increased and slender septa 
linked portal tracts and extended from the enlarged 
portal trinds into the surrounding parenchyma (Fig. 13). 
In two of the patients (Colorado Cases 6 and 7) this 
fibrosis was more extensive and the reitculin bands 
extended deeply into the lobules distorting the archi-
tecture and leading to the formation of small regenera-
tion nodules and micronodular cirrhosis (Fig. 14). Pro-
liferation of the bile ductules and cellular infiltration 
of the septa were not features of these cirrhotic livcrs. 
After portal diversion the size of the hepatocytes di-
FIG. 6. Anteroposterior intravenous urography in Case 4 before 
and 10 months after end-to-side portacaval shunt. Although the 
X-ray projec tions have slight differences. the length of the right 
ki<lneys appears to be decreased slightly. The bracket encompasses 
12 em. 
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FIG. 7. Five-hour glucose tolerance tests after the ingestion of 
1.75 Gm./Kg. of sugar in Cases 1 and 3. In both patients, the 
serum glucose after portal diversion showed higher and more 
persistent peaks. 
minished (Fig. 12, bottom) and the amount of fat in the 
cytoplasm of the liver cells increased. Both conditions 
persisted and were present as long as 1 year after 
operation (patient 3). 
In two of the patients (Colorado Case 1 and the 
Bristol patient), only postoperative biopsies were avail-
able for study. In the Colorado case, cirrhosis had been 
a very prominent feature of the preoperative biopsy 
9)f years previously as was recorded in the original 
case report,28 but the tissue block could not be found 
for re-study. There was no description of the hepatic 
morphology in the Bristol case report. By 1973, both 
these livers showed a micronodular cirrhosis similar to 
that present in Cases 6 and 7 but with the additional 
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FIG. 8. Insulin concentrations with 5-hour glucose tolerance tests 
in 6 Denver survivors and the Bristol case. (Left) Normal glucose 
and insulin responses (4): (right) glucose and insulin responses 
in glycogen storage dise,tse cases. 
feature of some bile ductule proliferation in the en-
larged portal tracts and in the fibrous septa. The he-
patoeytes in these two cases contained much fat and 
glycogen and appeared smaller than normal but the 
lack of a preoperative biopsy for comparative study 
TABLE 4. Effect of End-to-side Portacaval Anastomosis on Plasma Lipids 
Case Numbers* 
3 4 5 6 7 
Total Cholesterol (mg./lQO mI.) (Normal 138-242) (Normal 138-242) (Normal 138-242) (N ormal 138-242) (Normal 138--242) 
Before Hyperalimentatioll 460 408 224 324 389 
Preoperative 155 236 262 250 
2 Weeks Postoperative 125 190 306 161 171 
4-11 Months Postoperative 126 225 197 200 400 
Triglycerides (mg./100 mI.) (Normal 70-80) (N'ormall10-120) (NorhlalI00-110) ( :-J onna 1 50-60) (Normal 30 -40) 
Before Hyperalimentatioll 2800 899 167 383 487 
Preoperative 298 337 511 420 
2 Weeks Postoperative 198 359 274 109 221 
4-11 Months Postoperative 224 208 135 258 325 
Phospholipids (mg./l00 mI.) (Normal 192-337) (Normal 192-337) (Normal 192-337) (Normal 192-337) (Normal 192-337) 
Before Hyperalimentation 750 558 346 357 652 
Preoperative 168 357 420 487 
2 Weeks Postoperative 212 257 320 237 207 
4-11 Months Postoperative 109 243 254 282 640 
Nonesterified Fatty Acids 
(mEq./L.) (Normal 0.45-.90) (Normal 0.45-.90) (Normal 0.45-.90) (Normal 0.45-.90) (Normal 0.45-.90) 
Before Hyperalimentation 1.50 1.90 2.60 
Preoperative 0.45 0.44 0.43 
2 Weeks Postoperative 180 1.60 100 100 
4-11 Months Postoperative 0.43 0.75 172 144 154 
*Cases 3 and 4 were Type I; Case 5 was Type VI; and Cases 6 and 7 were Type III glycogen storage disease. 
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prevented any statement about the occurrence of atrophy 
after portal diversion. 
Tissue Chemistries 
Tissues were examined from biopsies before portal 
diversion in all Colorado cases. After portal diversion, 
wedge biopsies were obtained in Case 1. Cases 3-7 
had needle biopsies. The glycogen concentration was 
not altered from 5 to 113 months after portal diversion 
(Table 5). Enzyme concentrations in Case 1 were 
reported to be unaltered in Case 1 after 9 and 43 
months. There was not enough tissue in the needle bi-
opsies of Cases 3-7 to permit repeating the enzyme 
analyses. 
Follow-urJs Of Other Reported Cases 
The fate as of April, i973, of all previously reported 
patients known to have been submitted to portal di-
version is summarized in Table 6, including the Bristol 
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FIG. 10. Relief of hyperlipidemia in the same case as in Figure 9, 
but with the results expressed in lipoproteins as determined by 
cellulose acetate electrophoresis. The lipoproteins are expressed in 
three classes: alpha, beta (including the pre-beta component) 
and the omega (chylomicron) fractions. 
240 
FIG. 9. Effect of paren-
teral hyper alimentation 
and end.to-side porta-
caval shunt on the plasma 
lipids of patient 4 whose 
diagnosis was Type I 
glycogen storage disease. 
Note the amaZingly rapid 
and relatively complete 
reversal of all abnormal-
ities. 
patient who was actually brought to Denver and stud-
ied. The patient operated upon in Cleveland in 1967 
died p~ y~ars post-diversion of causes apparently un-
related to either the portal diversion or the enzymqtic 
defect for which it was performed. The other four 
children in whom portacaval shunts were performed 
have all benefited, in one instance despite thrombosis 
of the anastomosis. 
Discussion 
Recent animal work has indicated that the metabolic 
consequences of portal diversion are more complex as 
well as more profound than has been realized. The 
most important observations were with the kind of ca-
nine experiment that has been summarized schemati-
cally in terms of human anatomy in Figure 15. In 
these investigations, the splanchnic venous return was 
12 
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FIG. 11. Plasma uric acid values preoperatively and 5 to 11 
months postoperatively in five patients treated with end-to-side 
portacaval shunt. 
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FIG. 12. Biopsies from liver of patient 3. (Top) Imm ediately 
before operation; (Bottom) 10 months after portal diversion. 
The hepatocytes arc smaller in th e second biopsy than in the 
Rrst (H & Ex 280). 
divided so that one portion of the dog liver received 
the venous efHuent from the intestine and W,lS thus 
Ilutritionally enriched but hormonally deprived. This 
hepatic tissue under'vvcnt deglycogenation and gross 
shrinkage as well as atrophy of the individual herat. 
ocytes. The other liver fragment was nourished by pan-
creatieo-gastroduodeno-splenic venous blood and was 
shown by a series of biochemical examinations to bc 
hormone-directed, particularly by pancreatic insulin and 
glucagon. Despite being deprived of intcstinal nutrients, 
the latter hepatic tissue und erwent glycogen storage, 
hyper trophy, and hyperplasia .2G 
T hus, under the special conditions of this kinu of 
"double liver fragment" experiment, rerouting of pan· 
creatic hormones around the normal dog liver had a 
far greater effect upon hepatiC structure and function 
than the bypassing of vcnous blood rich in nutrients 
coming from the intestine. In trying to explain the ben· 
efits of portal diversion for glycogen storage disease, 
it is important to appreciate that with the procedures 
used for all our patients, both nutritional and hor-
monal substances were diverted extrahepatically and 
may havc contributed to the postoperative benefits. 
Of the metabolic corrections produced by portal di. 
vei'sion, the most dramatic were in the patients with 
Type I disease (Cases 3 and 4). These involved lipids 
to an even greater extent than carbohydrates. The pro-
found changes in lipid metabolism after portal diver-
sion in patients with Type I disease was first noted by 
Hermann and Mercerll and confirmed by Folkman et alB 
and in our own patients. The virtual normalization of 
all lipid constituents required only a few weeks for 
completion. 
The effect upon lipids did not seem to be secondary 
to a more fundamental change in carbohydrate me-
tabolism. Repeat liver biopsies did not show a changed 
concentration of glycogen. Furthermore, episodiC hy-
poglycemia \Vas not completely relieved by the portal 
diversion, although the seriousness of the problem was 
considerably reduced, as was the degree of accom-
panying acidosis. Both of these children with Type I 
disease continued to require supplemental night or early 
morning feedings. It was interesting that this require-
ment had long since disappea red for the Bristol patient 
who also had the glucose-6-phosphatase deficiency. 
Similarly, the portal diversion did not change the 
glycogen concentration in the livers of the three chil-
dren with Type III disease or the boy with the Type 
VI defect. The episodic hypoglycemia in two of the 
three patients with Type III disease could still be doc-
umented biochemically after long fasting or several 
hours after the ingestion of a glucose load, although 
again with less severity than preoperatively. In these 
cases, as well as in those with the Type I defect, some 
of the expected glycemic effects of diverting glucose · 
around the liver were probably cancelled by increasing 
the amount of insulin in the periphery. It is known 
that the liver extracts up to 50% of the endogenous in-
sulin presented to it by the first p,lSS of portal blood.1.l 6. 19 
\Vith avoidance of this primary exposure to the liver, 
Waddell and Sussman:1o demonstrated increased systemiC 
venous insulin in dogs with Eck fistula and others have 
shown the same thing in humans after portacaval 
phulltl~OEF A further hyperinsulinemic effect could then 
be caused after eating by stimulation of the pancrease by 
the arrival of a glucose load in the arterial circulation. 
Thus, failure to completely relieve hypoglycemiC symp-
toms by diverting alimentary glucose to the peripheral 
tissues Illay have been clue to one or the other or both 
the foregoing mech,1nisms. 
Because insulins were not measured preoperatively 
in any of our longest surviving patients, the extent is 
not known to which portal diversion actually changed 
the concentration of this hormone in their sys temiC 
blood. However, Lockwood et af.1' and Dr,1sh and 
FieldS have shown that victims of glycogen storage 
disease have abnormally low peripheral insulin concen-
trations under conditions of fasting or glucose inges-
tion. After portal diversion, all six of our survivors as 
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FIC. 13. Biopsy from liver of patient 5 immediately before porta I diversion. The amount of re ticulin in the portal trac ts is in creased 
and sep ta link portal tracts and extend into the surrou nding p arenchyma. Silver stain for reticulin (X 70). 
well as th e Bristol patient llacl insulin concen trations 
meas ured after stimulation with a glucose meal. Th e 
responses were supernormal in three of the seven cascs 
and normal in a fourth. Consequently , a reasonabl e 
although circumstantial case can be made that the in-
sulin supply to th e peripheral tissues had been increascd 
by the portal diversion. 
In recent yea rs, insulin has becn recognized to be a 
major grolVth horqll o f1 cI~ ~ cC ll1parable in potency to 
somatot ropin. It may he that the phenomenal grolVth 
sp urts of all of our long-surviving patien ts could be at 
least partly attribu table to an increased insulin d istri-
bution to the p c.: riphe ry. T he acccleratecl grow th could 
not be expLri li ed hy other factors such as relief of 
chronic acidosis or persistent hypoglycemi a since these 
werc sometimes not present prr peratively or else they 
were not comple tely corrected after th performance 
of the portacaval shun t. An effect on somatotropin would 
seem eq ually unlikely. In glycogen storage pati en ts 
studied by Dras b and Field," pl asma growth hormone has 
Iw cll normal and in the people studied by us with or 
without portal d iversion, the same was trlle. 
It is not presen tl y possible to precisely expl ain all the 
meta bolic benefits of portal diversion by a single hor-
monal or nutritional mechanism. " 'hy the platelet 
dysfunction should have been correc ted or why th e mani-
festations or ahnormal calciulll or uric ,leid metabolism 
should have been ameliorated are exam plc5. The exact 
reaso n for the li ver shrinkage obse rved in several pa-
ti cn ts by liver scans also is not apparent. Th e glycogen 
concentrations were not altered after portal divcrsion. 
However, the biopsies obtained several months Or longer 
after portal diversion revealed pronounced hepatocyte 
atrophy. With this finding which , in turn is mos t likely 
the consequences of horm one depriva tion (p articul<1rly 
in sulin) as discussed earlier, liver shr inkage could rea-
sonably occur without an accompanying chan ge in glyco -
gen concentr,ltion. 
';\,lith the new .:ases in·11 Id 'd in th e present report, 
the posi tion has been reinforced that simpl ' end-to-side 
pO'laca val sh unt is an effcctive and rela tively safe 
lllethod of palliating well selected patients with severe 
manifes tations of hepatic glycogenosis. 'Vhen porta l 
dive rsion was first considered for these diseases, anxi-
ety abou t th e complications of simple Eck fi stula 
prompted attempts at the metabolically less damaging 
536 STARZL AND OTHERS An n. Surg . • October 1973 
FIC. 14. Biopsy of liver of Patient 7 immediately before portal diversion. The normal lobular reticulin pattern has been destroyed 
and there is a micronodular cirrhosis . Silver stain for reticulin (X 70) . 
but technically more complicated operation of porta-
caval transposition. The fear that Eck fistula would 
have devastating effects on humans was based, at 
least in part, upon observations on two patients each 
by McDermott , Adams and Riddell 17 and Hubbard.14 
These four patients had carcinomas of the head of the 
pancreas which involved the portal vein. To permit 
partial pancreatectomy, the portal vein was resected 
and an end-to-side anastomosis was made between the 
superior mesenteric vein and the inferior vena cava. 
Three of the four patients died of inanition and at 
autopsy there was massive fatty infiltration of the liver. 
The syndrome was ascribed to the bypass of ammonia 
of intestinal origin around the liver and it was gen-
erally accepted that Eck fistula in humans with normal 
livers would be exceptionally dangerous. The fact that 
partial pancreatectomy was also performed was lost sight 
of. The recent research already alluded to about the 
hepatotrophic effects of pancreatic hormones has raised 
the question of whether or not the calamities of Mc-
Dermott and Hubbard were not due at least as much to 
the pancreatic resection as to the portal-systemic venous 
diversion . 
Be that as it may, the observations by us and by 
others authors have now established that simple end-
to-side portacaval anastomosis is weI! tolerated in chil-
dren with Types I, III or VI glycogen storage disease. 
Ammonia levels in our five patients with Eck fistula 
TABLES. Glycogen Contents of Liver Biopsies in the Colorado Cases 
Glycogen Content (% Wet Weight of Liver) 
Timeof Pre-
operative 
Before any Hyperalimen- At 
Case Treatment tation Diversion Postopera tive 
None 10.1 9.7 ( 9 
months) 
9.5 ( 43 
months) 
2 None 9.4 
.3 8.0(Aug.71) 29 days 11.0 8.9(1l} 
months) 
4 10.0 (1961 ) 13 days 5.2 7.7 ( 11 
months) 
5 None 12.6 1l.8( 8} 
months) 
6 6 da ys 10.6 12.2 ( 5 
month s) 
7 7 days 8.1 12.8 ( 5 
months) 
Vol. 178 • No.4 GLYCOGEN STORAGE DISEASE 537 
TABLE 6. Previously Reported Cases of Glycogen Storage Disease Treated with Portal Diversion 
G.S.D. Age at Operation 
Center Type (Years) Date of Operation Procedure Outcome 
Colorado25 •28 IIIB 8 10/63 
Bristol21 I 7 5/65 
(Riddell) 
Clevelandll 4/67 
(Hermann) 
Colorado25 7 6/68 
New York2 5 5/69 
(Boley) 
Columbus6 .:!. 6/70 • (Cia tworth y ) 
Boston 9 .3 7/71 
(Folkman) 
Boston9 2 11/71 
(Folkman) 
have always been normal and at no time has there 
been evidence of hepatic encephalopathy. Although en-
zyme increases were observed for several days after 
the performance of end-to-side portacaval shunt, these 
unquestionably reflected pre-existing liver disease in 
most if not all of the cases. After operation, deteriora-
tion of liver function did not occur. Biopsies of the 
livers after portal diversion generally showed an in-
crease in the amount of fat in the cytoplasm of the 
hepatocytes but did not show any progression in the 
amount of fibrosis or in the severity of the micronodular 
cirrhosis when this was present before operation. The 
frequency of scarring ranging from mild fibrosis to 
frank microndular cirrhosis in our cases before any 
operative intervention was surprising when the litera-
ture leads one to believe that fibrosis and cirrhosis are 
not complications of these types of glycogen storage 
disease. It is probable that closer attention to the patho-
logic findings will demonstrate a much higher incidence 
of fibrosis and cirrhosis than has been appreciated. 
Summary 
Seven patients with Types I, III, or VI glycogen 
storage disease were treated with portal diversion from 
RF~ months to 9g~ years ago. The first two patients had 
portacaval transposition with one early death. The last 
five patients had the technically safer procedure of end-
to-side portacaval shunt without any deaths and with 
no late findings of hepatic encephalopathy. The con-
valescence of the patients with either kind of portal 
diversion has been characterized by accelerated body 
growth and bone mineralization, incomplete relief of 
hypoglycemia and metabolic acidosis, striking ameliora-
tion of the hyperlipidemia of Type I disease, liver 
shrinkage in Types I and VI disease, and variable re-
lief of such diverse other derangements as abnormal 
bleeding and elevated serum uric acid concentrations. 
The liver concentrations of glycogen were not affected 
Transposition Alive 
Transposi tion Alive-Caval-portal anastomosis 
clotted 
Porta-caval shunt Died I! years 
Transposition Died 2 days 
Porta-caval shunt Alive 
Porta-caval shunt Alive-Shunt clotted 
Porta-caval shunt Alive 
Porta-caval shunt Alive 
by portal diversion. However, the hepatocytes were 
decreased in size in subsequent biopsies, thereby ac-
counting for the reduction of liver size in most of the 
cases without a major alteration in glycogen. Contrary 
to the impression conveyed by the literature, there was 
a high incidence of pre-existing coincidental liver dis-
ease in our patients, including transaminase elevations 
and hepatiC fibrosis or even cirrhosis. These abnormali-
ties were particularly striking in Type III patients but 
did not appear in any of the cases to be made worse by 
portal diversion. The observations in these seven pa-
tients and in six more reported from other centers and 
followed up with personal examination by us in Denver 
or by personal communication with the responsible 
physicians elsewhere indicate that portal diversion should 
• GLYCOGENATION 
f fkqbpqfk~i VENOUS 
(\, ..... --:~~ EFFLUENT 
,,-j /, 
FIG. 15. Summary of experimental results in recently repeated 
canine experiments (26) in which one portion of the liver 
received portal venous inflow from the pancreas and the other 
portion received inflow from the intestine. The "food dominated" 
hepatic fragment underwent atrophy and deglycogenation whereas 
the "hormone dominated" fragment had hypertrophy, hyperplasia, 
and glycogen storage. These experiments which permitted dis-
sociation of nutritional and hormonal influences indicated that 
the latter were more influential than the former in affecting liver 
structure and function. 
538 STARZL AND OTHERS Ann. Surg .• October 1973 
have an important role in carefully selectcd cases of 
glycogen storage disease. Recent work in our labora-
tories has been reviewed which suggests that the ef-
fects of pOliacaval shunt are due more to the rerout-
ing of pancreatic hormones around the liver than to the 
bypassing of alimentary glucose. 
References 
1. Blackard, \V. G. and Nelson, N. c.: Portal and Peripheral 
Vein Immunoreactive !nsulin Concentrations before and 
after Glucose Infusion. Diabetes, 19:302, 1970. 
2. Boley, S. J., Cohen, M. I. and Gliedman, M. L.: Surgical 
Therapy of Glycogen Storage Disease. Pediatrics, 46:929, 
1970. 
3. Brown, 1. and Brown, D. II.: Glvcogen Storage Discases, 
Types I, III, IV, V, VII and Unclassified Glycogenoses. 
In Carbohydrate Metabolism ancI Its Disorders. (Dickens, 
F., Randle, P. J. and Whelan, W. J., eds.). VOL. II. New 
York, Academic Press, 1968, pp. 123-150. 
4. Castro, A., Scott, J. P., Grettie, D. P., Macfarlane, D. and 
Bailey, R. K: Plasma Insulin and Glucose Response of 
Healthy Subjects to Varying Glucose Loads during Three-
hour Oral Glucose Tolerance Tests. Diahetes, 19: 842, 1970. 
. '5. Child, C. G., Barr, D., Holswac1e, G. R. and Harrison, C. S.: 
Liver Regeneration following Portacaval Transposition in 
Dogs. Ann. Surg., 138: 600, 1953. 
6. Clatworth\" W. Discussion of Folkman, J., Philippart, A., Tze, 
W.-J., ~nd Crigler, J., Jr.: Portacaval Shunt for dlycoge~ 
Storage Disease: Value of Prolonged Intravenous Hyperah-
mentation before Surgery. Surgery, 72:306, 1972. 
7. Corby, D. G., Shigeta, F. H., Greene, H. L. ancl Steifel, F. B.: 
Platelct Dvsfunction in Glycogen Storage Disease Tvpe I: 
Reversal \vith Total Parental Nutrition. Clin. Res., 21: :304, 
1973. 
8. Drash, A. and Fielel, J.: The Glycogen Storage Diseases. Dis-
ease-A-Month, Oct. 1971, pp. 3-40. 
9. Folkman, J., Philippart, A., Tze, W.-J. and Crigler, J., Jr.: 
Portacaval Shunt for Glycogen Storage Disease: Value of 
Prolonged Intravenous Hyperalimentation bcfore Surgery. 
Surgery, 72::306, 1972. 
10. Greulich, \V. W. and Pyle, S. I.: Radiographic Atlas of 
Skeletal Dt'velopment of the H ancl and \Vrist (2nd Edi-
tion). Stanford, Stanford University Press, 1959. 
11. Hermann, H. E. and Mercer, R. D.: Portacaval Shunt in the 
Treatment of Glycogen Storage Disease: Report of a Case. 
Surgery, 65:499, 1969. 
12. Holdsworth, C. D., Nyc, L. and King, K: The Effect of 
Portacaval Anastomosis on Oral Carbohydrate Tolerance 
and on Plasma Insulin Levels. Gut, 13:58, 1972. 
1:3. Howell, R. R.: The Glycogen Storage Diseases. In The l\Ieta-
bolic Basis of Inherited Disl'ase, 3rd Edition. Stanlmr)" 
J. B., Wyngaanlen, J. B. and Fredrickson, D. S., e(ls.). 
New York, McGraw-Hill, 1972, pp. 149-173. 
14. Hubhard, T. B.: Carcinoma of the Head of the Pancrf'as: 
Resection of tllP Portal Vein and Portacaval Shunt. Ann. 
Surg., 147:9:35, 1958. . 
15. Lockwood, D. H., Mcrimee, T. J., Edgar, P. J., Greene, 
M. L., Fujimoto, W. Y., Seegmiller, J. E. and Howell, 
R. H.: Insulin Secretion in Type I Glycogen Storage Dis-
ease. Diabetes, 18:755, 1969. 
16. Madison, L. L., Combes, B., Unger, R. H. and Kaplan, N.: 
The Relationship between the Mechanism of Actions of the 
Sulfonvlureas ami the Secretion of Insulin into the Portal 
Circulation. Ann. N.Y. Acad. Sci., 74:548, 1959. 
17. McDermott, W. V., Jr., Adams, R. D. and Riddell, A. G.: 
Ammonia Metabolism in Man. Ann. Surg., 140:539, 1954. 
18. 
19. 
20. 
21. 
22. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
Morgan, C. R. and Lazarow, A.: Immunoassay of Insulin: Two 
Antibody System. Plasma Insulin Levels of Normal, Sub-
diabetic and Diabetic Rats. Diabetes, 12: 115, 1963. 
Mortimorc, G. E. and Tietze, F.: Studies on the Mechanism 
of Capture and Degradation of Insulin p31 by the Cycli-
cally Perfused Rat Liver. Ann. N.Y. Acad. Sci., 82:329, 
1959. 
Perley, M. J. and Kipnis, D. M.: Plasma Insulin Responses to 
Oral and Intravenous Glucose: Studies in Normal and 
Diabetic Subjects. J. CHn. Invest., 46: 1954, 1967. 
Riddell, A. G., Davies, R. P. and .Clark, A. D.: Portacaval 
Transposition in the Treatment of Glycogen-storage Dis-
ease. Lancet, 2: 1146, 1966. 
Schmid, R.: Clinical Manifestation of Glycogen Storage Dis-
eases. In Control of Glycogen Metabolism. (Whelan, W. J. 
and Cameron, M. P., eds.). Boston, Little, Brown & Co., 
1964, pp. 305-317. 
Sexton, A. W., Marchioro, T. 1,., Waddell, W. R. and Starzl, 
T. E.: Liver Deglycogenation after Portacaval Transposi-
tion. Surg. Forum, 15: 120, 1964. 
Snipes, C. A.: Effects of Growth Hormone and Insulin on 
Amino Acid and Protein Metabolism. Quart. Rev. BioI., 
43: 127, 1968. 
Starzl, T. E., Brown, B. I., Blanchard, H. and Brettschneider, 
L.: Portal Diversion in Glycogen Storage Disease. Surgery, 
65:504, 1969 . 
Starzl, T. E., Francavilla, A., Halgrimson, C. G., Francavilla, 
F. R., Porter, K. A., Brown, T. H. and Putnam, C. .: The 
Origin, Hormonal Nature, and Action of Portal Venous 
Hepatotrophic Substances. Surg. Gynccol. Obstct. 37: 179, 
1973. 
Starzl, T. K, Groth, C. G. and Brf'ttschneider, L.: An 
Everting Technique for Intraluminal Vascular Suturing. 
Surg. Gynecol. Obstet., 123: 125, 1968. 
Starzl, T. K, Marchioro, T. L., Sexton, A. W., Illingworth, 
B., Waddell, W. R., Faris, T. D. and Hermann, T. J.: 
Thf' Eflect of Portacaval Transposition on Carbohydrate 
Metaholism: Experimental ami Clinical Obscl'\'atiolls. Sur-
gery, 57:687, 1965. 
Sussman, L. N., Cohen, I. B. and Gittler, R.: Clinical Applica-
tion of Simplified Prothrombin Cor.snmption Test. JAYlA, 
156:702, 1954. 
\VadcIclI, \V. R. and Sussman, K. E.: Plasma Insulin after 
Diversion of Portal and Pancreatic Venous Blood to Vena 
Cava. J. Appl. Physiol., 22:808, 1967. 
Wright, H. P.: The Adhesiveness of Blood Platelets in :\ormal 
Subjects with Varying Concentrations of Anticoagulants. 
J. Path. Bact., 53:255, 1941. 
DISCUSSION 
DR. W. KlRT NICHOLS (Columbia): Let me share with you a 
similar instance of glycogen storage disease, Type III with portal 
hypertension trcated at the UniVl'rsity of Missouri Medical Center 
by Dr. Hugh Stf'phenson and mysclf. 
(Slide) Thc patient is a 31-year-old caucasian male whose his-
tory dates back to childhood when he was evaluated during his 
first year of life, hecause of listlessness, irritability and a history 
of bleeding. Bccause of hepatosplenomegaly, a livcr biopsy was 
performed with a subsequcnt diagnOSis of Von Gierke's disease. 
He was reevaluated in another hospital in 1956 and 1960 for 
retarded physical ami sexual growth. Again, hepatosplenomegaly 
was noted. Liver biopsy (slide) showed irregular fibrosis and 
evidence of incrcased glycogen dcposition. Fasting serum glucose 
levels were low. 
In 1965 he was evaluated at another university hospital. Liver 
biopsy was again performed. Thc tissue was biochemically ana-
lyzed and the amylo-l, 6 glucosidase enzyme, or c\('hrancher 
enzyme, was found to be defective. 
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Leukocyte enzyme studies were performed and no amylo-l, 6 
glucosidase activity was found. Normal levels of phosphorylase 
and amylo-( 1, 4-1, 6)-transglucosidase were found. 
Ill' came to the Universitv of Missouri Medical Center in Jan-
nary 1973 with a 3-day history of melana and noticeahle ortho-
static changes. Ill' gave a past history of peptic ulcer disease. 
However, an upper gastrointestinal series performed 6 months 
earlier at our institution showed only spasm in the duodenum. 
Castroduodenoscopy on admission revealcd no ulcer, only esopha-
geal varices. Castric analysis was normal. Liver function tests 
wert' essentially normal except for an elevated alkaline phos-
phatase and LDH. 
( Slide) A splenoportogram was performed and the splenic pulp 
pressure was 340 millimeters of saline. The X-rays were inter-
preted as showing evidence of portal hypertension. 
After conferring with our gastroenterologist and finding some 
support for portal diversion ill Dr. Starzl's, Dr. Herman and Dr. 
Mercer's work, we decided to perform a side-to-side portacaval 
shunt. Portal venous pressures prior to construction of the shunt 
\\l'H' 275 millimeters of saline and after shunting were 185 milli-
meters of saline. A Dopplt'f ultrasonic flowmeter was used intra-
operatively to confirm the patency of our shunt. Liver biopsy 
again rcveals irregular fibrosis, (slide) as seen in this reticulum 
stain; frozen section stained (slide) with PAS; and after diatase 
digestion (slide) demonstrates increased glvcogcn. 
Postoperatively, a splenoportogram shows a (slide) patent 
portacaval anastomosis. The patient is now 3 months postoperative 
and doing well although he now manifests some evidence of 
diabetes with persistent hyperglycemia. I would like to ask Dr. 
Starzl if this has been a problem with any of his paticnts and 
sllotdd he now b(' managed as a diabetic? 
Secondly, since cirrhosis has not been commonly reported in 
Typc III glycogen storagr' disease, I would like to ask if cirrhosis 
has been a common finding in his patients with Type III glycogen 
storage disease. 
DB. JUDAH cEFih~fAk (Boston): Children with glycogen storage 
disease suffer primarily because caloric intake gets trappcd as 
glycogen in the liver and cannot escape as glucose. 
Thes(' children have hypoglycemic seizures. Their parents are 
often up all Ilight feeding th('m. They have acidosis. They have 
muscl(' wasting ancl above all, they do not grow, as Dr. Starzl 
pointed out. 
Dr. Starzl was the first to realize, actually in 1963, that diver-
sion of portal blood around the liver might make more glucose 
available to the peripheral circulation aftt'r each mcal and he 
carried out the first portal diversion for this disease. 
In the intervcning years, there were four reports by surgeons 
each citing Oll(' case that he had clone of portal diversion for 
this disease, hut there was high morbidity and significant mor-
talitv because these little children are very sick going into the 
op('ration. Thn arc acidotic. Their pH is about 7.1 or 7.2. Their 
abdoJl]cn is filled with a hnge liver and this makes the operation 
difficult. 
vVe have found that the operative risk could be reduced by 
preparing these children with 3 weeks of hyperalimentation. This 
cOITeds the acidosis and shrinks the liver to actually 50% of its 
size, reducl's the lipids to normal levels and makes the operation 
much more easy. 
Last year, we reported two sneh cases to the Society of Uni-
vcrsity Surgeons in which hvperalimentatioll preceded portal caval 
shunt :lnd, like Dr. Starzl's cases, there was phenomenal growth 
after the shunt. 
For example, in one of these boys-here he is at 20 months of 
age and 19 davs after a portal l'aval shnnt, \OU can see xanthomas 
wbich are disappearing because he has l~ml hyperalimentation. 
This liver looks !Jig now, but this is half of its original size before 
hyperalimentation. This is a picture taken 2 weeks ago, 1 year and 
,3 months after operation and he is becoming a very big boy! He 
is eating all the time and growing and beginning to move from the 
fifth percentile to the ninety-fifth percentile. He is beginning to 
develop like a normal boy. 
What is the mechanism besides redirection of glucose into the 
bloodstream? Dr. Starzl's elegant studies indicate that redirection 
of insulin directly into the vena cava without passage through the 
liver, also plays a role; that insulin in this situation may itself he 
a growth stimulant. When I read his paper and saw the abstract, 
I wished that I had thought of that because we had always 
assumed that the phcnomenal growth was primarily the result of 
increased glucose availabilitv. But, in fact, the tissue culture 
literature of recent years is filled with papers showing that insulin 
or insulin-like proteins ha:ve specific growth stimulating properties. 
Several post-doctoral fellows in our laboratory have studied this 
effect in cultured cells. I, thus, have had the opportunity to ob-
serve at once the growth spurt in the cells and also in our two 
patients ... hnt, the importance of insulin in the growth of our 
patients did not occur to me as it did to Dr. Starz!' 
I can only put this down to "snowblindness." On the wall of 
our laboratory, we have listed the various pitfalls in the art of 
making obscrvations. Snowhlindness is one of them. It is the pitfall 
of making the wrong interpretation in the presence of all the 
right facts. An example par excellence is recorded in Lister's 
Commonplace-Books (now in the library of the Royal College 
of Surgeons). Aftcr Lister had become famous for establishing 
antiseptic surgery, he made another observation, recorded under 
the date, November 25, 1871. He noticed that numerous hacteria 
in a tube of urine were "completely immobile and languid." He 
also noticed the presence of a soft mold on the surface of the 
urine, which he thought was a penicillium mold. He made some 
experiments to see if the growth of mold made the liquid an 
unfavorable medium for bacteria. But he came to the erroneous 
conclusion that what was happening was a competitive struggle 
for oxygen, the penicillium absorbing oxygen contained in the 
broth and hlocking the surface. 
vVe are indehted to Dr. Starz!'s group for showing llS that 
insulin may be acting as a growth stimulant. This contributes 
much to our understanding of the several beneficial effects of 
portal caval shunt in glycogen storage disease. Last, but not least, 
we are happy to see that they used hyperalimentation to prepare 
these children for shunt surgery, since this tends to confirm our 
own thinking that hyperalimentation reduces the operative risk 
in these patients. 
DR. T. E. STARZL (Closing): Concerning the snow blindness, 
I am strongly tempted to reveal examples of this disease of my 
own making but I will refrain because the crowd is so small and 
the time is so late that there would be an inappropriately small 
number of witnesses! 
Dr. Nichols, the literature leaves the probably crroneous im-
preSSion that glycogen storage disease is rarely associated with 
fibrosis. However, in our case material pre-existing fibrotic or 
cirrhotic disease was universal. This was a particularly important 
finding in the patients with Type III disease. 
Concerning the elevated blood sugar levels in your patient after 
portacaval shunt, I have found in dogs made diabetic with 
alloxan that portal diversion is a slightly diabetogenic procedure 
for reasons that I do not think we have time to go into today 
(Surgery, 45:531, 1959). Dr. William Waddell has observed the 
same finding under somewhat different conditions of portal diver-
sion. Such findings would go along with the events you saw in 
your patient, bllt I wOllld not antiCipate management of the 
diabetes would be a serious problem. 
As Dr. Folkman said, the role of insulin in accelerating the 
growth of these shlllted children is one of the key questions 
raised by my presentation today. Reflecting hack 40 or 50 years 
ago, it may be recalled that there were "diahetic dwarfs" in those 
davs before hormone therapy became available. This complication 
is not seen anymore for obvious reasons. But it is possible that 
the diabetic dwarfs of that era and the dwarfism that is seen in 
the glycogen storage disease patients of today have the common 
explanation of insulinopenia. 
